These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36145390)
21. Are We Forgetting About IgA? A Re-examination of Coronavirus Disease 2019 Convalescent Plasma. Verkerke H; Saeedi BJ; Boyer D; Allen JW; Owens J; Shin S; Horwath M; Patel K; Paul A; Wu SC; Wang J; Ho A; Maier CL; Zerra PE; Chonat S; Arthur CM; Roback JD; Neish AS; Lough C; Josephson CD; Stowell SR Transfusion; 2021 Jun; 61(6):1740-1748. PubMed ID: 34041759 [TBL] [Abstract][Full Text] [Related]
22. Influential factor and trend of specific IgG antibody titer in coronavirus disease 2019 convalescents. Wu C; Liu W; Li G; Zhang Z; Xiao K; LE A Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 45(10):1172-1175. PubMed ID: 33268577 [TBL] [Abstract][Full Text] [Related]
23. Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India. Jain R; Mallya MV; Amoncar S; Palyekar S; Adsul HP; Kumar R; Chawla S Transfus Clin Biol; 2022 Feb; 29(1):60-64. PubMed ID: 34302953 [TBL] [Abstract][Full Text] [Related]
24. Anti-SARS-CoV-2 Serology persistence over time in COVID-19 Convalescent Plasma Donors. De Giorgi V; West KA; Henning AN; Chen L; Holbrook MR; Gross R; Liang J; Postnikova E; Trenbeath J; Pogue S; Scinto T; Alter HJ; Cantilena CC medRxiv; 2021 Mar; ():. PubMed ID: 33758897 [TBL] [Abstract][Full Text] [Related]
25. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial. Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ Trials; 2021 May; 22(1):342. PubMed ID: 34001174 [TBL] [Abstract][Full Text] [Related]
26. Convalescent plasma as an adjunctive therapy for COVID-19: A single centre experience in Malaysia. Lee KT; Yeoh WC; Zainul NH; Syed Alwi SB; Low LL Med J Malaysia; 2021 Sep; 76(5):653-657. PubMed ID: 34508370 [TBL] [Abstract][Full Text] [Related]
27. Convalescent plasma therapy in patients with severe COVID-19, A single-arm, retrospective study. Ghadami L; Hasibi M; Asadollahi-Amin A; Asanjarani B; Farahmand M; Abdollahi H Microb Pathog; 2022 Apr; 165():105482. PubMed ID: 35288278 [TBL] [Abstract][Full Text] [Related]
28. Convalescent Plasma to Treat COVID-19: A Two-Center, Randomized, Double-Blind Clinical Trial. Ventura-Enríquez Y; Cabello-Gutiérrez C; Pérez-Calatayud ÁA; Cortina-De la Rosa E; Fareli-González CJ; Castillo-Juárez P; Carlos AP; Zavaleta-Martínez EO; Diaz-Padilla E; Murrieta S; Álvarez-Jiménez VD; Ponce-Medrano JAD; Casillas-Suárez C; Ocampo-Ocampo MA; Vargas-De-León C; Fernández-Sánchez V Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36362922 [TBL] [Abstract][Full Text] [Related]